Business / Finance

RSS

Affiliate of American Securities enters into definitive agreement to recapitalize Aspen Dental

American Securities LLC, Ares Management, L.P., and Leonard Green & Partners, L.P. today announced that an affiliate of American Securities has entered into a definitive agreement to recapitalize Aspen Dental Management Inc. in partnership with the management team and funds affiliated with Ares and Leonard Green. Terms of the transaction were not disclosed.

24 Mar 2015

Bruker’s new Wine and Honey screeners deliver easy, comprehensive cost efficient analysis

The inherent ease of use allows non-expert users to conduct analyses from measurement to final report in minutes and without chromatography.

23 Mar 2015

Cipher to distribute Can-Fite’s CF101 for plaque psoriasis and rheumatoid arthritis treatment in Canada

Cipher Pharmaceuticals Inc. today announced it has licensed the Canadian distribution rights to CF101, a novel chemical entity being developed by Can-Fite Biopharma for moderate to severe plaque psoriasis and rheumatoid arthritis.

23 Mar 2015

OrthoSensor raises $19 million in Series C Preferred Stock financing

OrthoSensor, Inc., the leader in Sensor-Assisted Surgery, announced today that it has raised $19 million in a private placement of Series C Preferred Stock. Bridger Healthcare, Ltd. and The Tullis Growth Fund, L.P. participated in the round. The proceeds will be used to drive the commercialization of VERASENSE, OrthoSensor's leading product, and expand product development activities.

23 Mar 2015

Everyday Health announces acquisition of Cambridge BioMarketing Group

Everyday Health, Inc., a leading provider of digital health and wellness solutions, today acquired Cambridge BioMarketing Group, LLC, the leader in strategic launch and marketing solutions for orphan and rare disease products.

23 Mar 2015

Can-Fite, Cipher Pharmaceuticals sign agreement to distribute CF101 in Canada

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has signed a distribution agreement with Cipher Pharmaceuticals Inc. to distribute Can-Fite's lead drug candidate, CF101, for the treatment of moderate to severe psoriasis and rheumatoid arthritis in the Canadian market upon receipt of regulatory approvals.

23 Mar 2015

GenVec collaborates with TheraBiologics to develop NSC-mediated cancer therapeutics

GenVec, Inc. today announced that it has formed a collaboration with TheraBiologics to develop cancer therapeutics leveraging both GenVec's proprietary gene delivery platform and TheraBiologics' proprietary neural stem cell (NSC) technology.

23 Mar 2015

Eli Lilly, Innovent Biologics announce biotech drug development collaborations in China

Eli Lilly and Company and Innovent Biologics, Inc. today announced one of the largest biotech drug development collaborations in China to date between a multi-national and domestic company.

21 Mar 2015

96-well glass vial storage plate for UHPLC

Porvair Sciences glass vial storage plate combines 96 borosilicate glass vials of 700µl into a rigid polypropylene carrier microplate to provide a superior product for storage and transportation applications.

19 Mar 2015

Allscripts to market NoteSwift 2.0 for Allscripts Professional EHR

NoteSwift, Inc. and Allscripts have entered into an agreement for Allscripts to market and resell NoteSwift 2.0 for Allscripts Professional EHR. In response to customer demand, this strategic agreement may help providers reduce the time spent on creating patient documentation by more than half through the use of medical speech recognition.

19 Mar 2015

INTEGRA Biosciences announces opening of German subsidiary

Following on from the successful launch of subsidiaries in France, the UK and the USA - INTEGRA Biosciences has announced the opening in January 2015 of a new organisation based in Konstanz, Germany.

From INTEGRA Biosciences 19 Mar 2015

AbbVie signs exclusive worldwide license agreement with C2N for Alzheimer's disease therapies

AbbVie today announced that it has entered into an exclusive worldwide license agreement with C2N Diagnostics, a privately held protein diagnostic and therapeutic discovery company, to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease and other neurological disorders.

19 Mar 2015

Antech Diagnostics agrees to acquire assets of AVRL for $21 million from Abaxis

Abaxis, Inc., a medical products company manufacturing point-of-care blood analysis systems, and VCA Inc., a leading animal healthcare company in the United States and Canada, today jointly announced Antech Diagnostics, Inc., VCA's laboratory division, has agreed to acquire the assets of AVRL (Abaxis Veterinary Reference Laboratory) from Abaxis for $21 million in cash.

19 Mar 2015

Sigma-Aldrich, Roche sign distribution agreement for Biochemical Reagents products

Sigma-AldrichCorporation, a leading Life Science and Technology company, announced today it signed an exclusive global distribution agreement with Roche. The agreement pairs Roche's high-quality Biochemical Reagents product portfolio with the industry-leading eCommerce and supply chain capabilities of Sigma-Aldrich.

19 Mar 2015

ImmunoCellular, PharmaCell sign manufacturing agreement for European production of ICT-107

ImmunoCellular Therapeutics, Ltd. today announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM).

19 Mar 2015

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

Daiichi Sankyo, Inc. today announced a co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol) in the US, in line with the Daiichi Sankyo strategy to expand its US portfolio through strategic alliances, in addition to internal R&D and acquisitions.

19 Mar 2015

Ensocare to serve as authorized re-seller for iMPak's medication management system

An agreement was reached today between Ensocare and New Jersey-based iMPak Health to include iMPak's innovative medication management system, Kraken, as part of the Ensocare sales portfolio. Ensocare will serve as an authorized re-seller for the Kraken system, which may be sold alone or, in the future, as an integrated feature inside of Ensocare's Sync and Connect software engines.

19 Mar 2015

Janssen announces acquisition of XO1

Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired XO1 Limited, a privately held asset-centric virtual biopharmaceutical company founded to develop the anti-thrombin antibody ichorcumab.

19 Mar 2015

SST Group to become exclusive distributor for MPTronic's RDM solution in U.S. and Canada

SST Group, Inc., a leading provider of DICOM distribution solutions in the United States, is excited to announce its partnership with MPTronic, a leading developer of Radiation Dose Monitoring systems in Europe, Middle East and Africa.

18 Mar 2015

RMANJ acquires IVF New Jersey

Reproductive Medicine Associates of New Jersey, a world-renowned leader in the field of infertility, today announced the strategic acquisition of IVF New Jersey Fertility and Gynecology Center, one of the largest fertility centers in New Jersey.

18 Mar 2015

Business / Finance

Affiliate of American Securities enters into definitive agreement to recapitalize Aspen Dental

Bruker’s new Wine and Honey screeners deliver easy, comprehensive cost efficient analysis

Cipher to distribute Can-Fite’s CF101 for plaque psoriasis and rheumatoid arthritis treatment in Canada

OrthoSensor raises $19 million in Series C Preferred Stock financing

Everyday Health announces acquisition of Cambridge BioMarketing Group

Can-Fite, Cipher Pharmaceuticals sign agreement to distribute CF101 in Canada

GenVec collaborates with TheraBiologics to develop NSC-mediated cancer therapeutics

Eli Lilly, Innovent Biologics announce biotech drug development collaborations in China

96-well glass vial storage plate for UHPLC

Allscripts to market NoteSwift 2.0 for Allscripts Professional EHR

INTEGRA Biosciences announces opening of German subsidiary

AbbVie signs exclusive worldwide license agreement with C2N for Alzheimer's disease therapies

Antech Diagnostics agrees to acquire assets of AVRL for $21 million from Abaxis

Sigma-Aldrich, Roche sign distribution agreement for Biochemical Reagents products

ImmunoCellular, PharmaCell sign manufacturing agreement for European production of ICT-107

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

Ensocare to serve as authorized re-seller for iMPak's medication management system

Janssen announces acquisition of XO1

SST Group to become exclusive distributor for MPTronic's RDM solution in U.S. and Canada

RMANJ acquires IVF New Jersey

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News